Current Therapeutic Approaches in Infantile Colic: A Comprehensive Review

Vefik Arica1, Emine Gözde Özdrama Yildiz1, Sevilay Kök1

  • 1Department of Pediatrics, University of Health Sciences, Prof. Dr. Cemil Taşcıoğlu City Hospital, Istanbul, Türkiye.

Insights

Infantile colic (IC) management benefits from targeted feeding strategies and specific probiotics. Lactase enzyme may help when lactose malabsorption is suspected, but simethicone is not routinely recommended.

Area of Science:

  • Pediatrics
  • Gastroenterology
  • Nutritional Science

Background:

  • Infantile colic (IC) is a common functional gastrointestinal disorder characterized by prolonged crying in healthy infants.
  • Current management strategies for IC often yield inconsistent therapeutic outcomes.
  • There is a need for evidence-based, phenotype-guided approaches to manage IC.

Purpose of the Study:

  • To synthesize current evidence on the diagnosis and management of infantile colic.
  • To emphasize feeding strategies, maternal diet, and the role of lactose malabsorption.
  • To provide an evidence-based summary for managing IC.

Main Methods:

  • A narrative review of studies published between 2000 and 2025.
  • Searches conducted in PubMed, Scopus, and Google Scholar using keywords related to infantile colic, functional gastrointestinal disorders, lactase, probiotics, and maternal diet.
  • Selection and synthesis of relevant randomized controlled trials, meta-analyses, and clinical guidelines.

Main Results:

  • Targeted nutritional approaches, phenotype-guided probiotic use, and maternal dietary adjustments reduce crying duration and caregiver stress.
  • Specific probiotic strains (Lactobacillus reuteri DSM 17938 for breastfed; Bifidobacterium breve strains for bottle-fed) and lactase enzyme show moderate benefit.
  • Simethicone demonstrates no consistent efficacy and is not routinely recommended.

Conclusions:

  • Infantile colic is a self-limited but distressing condition requiring family-centered counseling and phenotype-specific interventions.
  • A stepwise, phenotype-guided approach integrating feeding optimization, dietary trials, and targeted probiotics is supported by evidence.
  • Practical guidance and red-flag features aid in phenotype-guided care for infantile colic.
Abstract

Related Concept Videos

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
Irritable Bowel Syndrome III: Medical and Nursing Management01:30

Irritable Bowel Syndrome III: Medical and Nursing Management

Managing Irritable Bowel Syndrome (IBS) involves a multifaceted approach, including lifestyle modifications, dietary changes, and medication.
Inflammatory Bowel Disease IV: Pharmacological Management01:29

Inflammatory Bowel Disease IV: Pharmacological Management

Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation01:30

Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation

Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
Inflammatory Bowel Disease V: Surgical Management01:21

Inflammatory Bowel Disease V: Surgical Management

Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...